Our articles provide quick read summaries to help keep you informed and looking forward with industry insights.
Before drug developers can claim that a drug effectively treats or cures a disease, they must provide clear, measurable evidence. Clinical trial endpoints are that evidence....
Read our article for an overview of early phase CAR-T studies in solid tumors....
Basket trials are a powerful tool in neuro-oncology, enabling the efficient study of rare and diverse CNS tumors. Learn about the benefits, potential imaging-related challenges, and possible solutions in our article....
Most brain cancer diagnoses in the United States are glioma, and MERIT’s webinar explored the challenges and potential solutions for assessing these tumors. New therapies are being studied through clinical trials, many of which use response criteria such as Response Assessment in Neuro-Oncology (RANO). This...
Idiopathic Pulmonary Fibrosis (IPF) is the most common type of PF, and its prevalence is on the rise globally. Numerous Phase 2 and Phase 2b/3 trials are underway for the development of new IPF treatments. ...
Discover 4 reasons to partner with a clinical endpoint expert for your next respiratory trial....
Learn five facts about the current state of clinical trials including details about trial costs, enrollment issues, and the difficulty and complexity of today's studies....
Given that the relative survival rate of patients diagnosed with metastatic lung cancer is low, and that traditional chemotherapy and surgery are of limited efficacy, ADCs represent a potentially important treatment option....
MERIT’s most recent webinar provided an interactive Q & A style session discussing how early phase centralized image storage can help sponsors secure funding. ...
Our ophthalmology case studies illustrate how we seamlessly manage the imaging components of your trial, creating efficiencies for your drug development. ...
This article provides a brief overview of Geographic Atrophy (GA) treatments under development....
MERIT’s respiratory case studies demonstrate that our quality overreads, fast turnaround times, and easy-to-reach RTs will help you move your trial forward....